Federico Grossi
CIK 1720634 · Chief Medical Officer · last filed 2025-01-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
63
Lifetime Open-Market Net
-$2.23M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Unity Biotechnology, Inc. (UBX) Delisted | Chief Medical Officer | — | $0.20 | — | $0 | 1 | 2025-01-07 |
| Apellis Pharmaceuticals, Inc. (APLS) Delisted | Chief Medical Officer | 94,884 | $41.03 | $3.89M | -$2.23M | 62 | 2023-01-09 |
Recent Filings · Page 6 of 7
63 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-11-17 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +5,750 | $18.4K | EDGAR |
| 2020-11-03 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −600 | -$18.7K | EDGAR |
| 2020-10-02 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −600 | -$18.1K | EDGAR |
| 2020-09-02 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −600 | -$18.9K | EDGAR |
| 2020-08-05 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −600 | -$15.8K | EDGAR |
| 2020-07-02 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −850 | -$27.6K | EDGAR |
| 2020-06-16 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Sell (S) | −856 | -$25.9K | EDGAR |
| 2020-02-12 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | +9,375 | $0 | EDGAR |
| 2019-02-12 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-11-15 | Apellis Pharmaceuticals, Inc. (APLS) Delisted | Exer (M) | +6,250 | $20.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.